Exane BNP Paribas initiated coverage of Phibro Animal Health with an Underperform rating and $9 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on PAHC:
- Phibro Animal Health price target lowered to $13 from $21 at Roth MKM
- Phibro Animal Health price target lowered to $10 from $17 at Barclays
- Phibro Animal Health cuts FY24 EPS view to $1.04-$1.16 from $1.12-$1.27
- Phibro Animal Health reports Q1 adjusted EPS 14c, consensus 23c
- Phibro ‘extremely disappointed’ in actions taken by FDA, to defend Mecadox use